Kristy Townsend, University of º£½ÇÉçÇø alumna and former faculty member, and cofounder of Neuright Inc., will lead a discussion, “Neuright Inc. Tackles Peripheral Neuropathy — Catch It Early, Fix It Fast,” as part of the Innovation Blender series sponsored by º£½ÇÉçÇøHealth Innovation and The Roux Institute. The event is noon–12:45 p.m. EST March 15 via Zoom. .
Neuright is a Uº£½ÇÉçÇø biotech start-up and academic spin-out company that has commercialized a new patent-pending theragnostic medical device for peripheral neuropathy, a condition of nerve death in tissues and organs that is common with aging, diabetes, and more than 30 other diseases and disorders. Founders Townsend and former Uº£½ÇÉçÇø graduate student Magdalena Blaszkiewicz have recently partnered with neurologists at The Ohio State University to begin comprehensive first-in-human testing comparing healthy and neuropathic patients and have begun developing a diagnostic algorithm from their nerve activity data. Learn more about .
